Clinical Trials Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Apr 14, 2017; 23(14): 2601-2612
Published online Apr 14, 2017. doi: 10.3748/wjg.v23.i14.2601
Table 4 Relationship of squamous/adenosquamous carcinoma clinicopathological parameters and ROR2 and WNT5a expression with average survival
GroupingNumber of cases, nAverage survival in moχ2P value
Sex
Male1910.74 (6-24)0.7670.381
Female279.85 (4-24)
Age, yr
≤ 45315.67 (8-24)2.0230.155
> 45439.84 (4-25)
Pathological type
Squamous carcinoma2610.19 (4-24)0.2230.637
Adenosquamous carcinoma2010.25 (4-24)
Degree of differentiation
High1613.81 (5-24)19.1250.000
Moderate248.92 (4-18)
Poor65.83 (4-9)
Maximal diameter of the mass, cm
≤ 32014.35 (7-24)31.3370.000
> 3267.04 (4-11)
Gallstones
No188.22 (4-12)3.7300.053
Yes2811.50 (4-24)
TNM stage
I + II1217.00 (9-24)51.1390.000
III209.20 (7-15)
IV145.86 (4-8)
Lymph node metastasis
No1714.24 (4-24)16.2190.000
Yes297.86 (4-15)
Invasion of the surrounding tissue
No1615.75 (9-24)32.2710.000
Yes307.27 (4-12)
Surgical procedure
Radical1416.64 (10-24)50.1650.000
Palliative188.50 (6-12)
Unresected146.00 (4-8)
ROR2
-2013.65 (6-24)16.5020.000
+267.58 (4-15)
WNT5a
-1713.77 (6-24)10.8440.001
+298.14 (4-15)